The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Hill-Rom Holdings Inc

NYSE: HRC
Last

(U.S.) $47.92

Today's change+0.18 +0.38%
Updated February 27 4:02 PM EST. Delayed by at least 15 minutes.
 

Hill-Rom Holdings Inc

NYSE: HRC
Last

(U.S.) $47.92

Today's change+0.18 +0.38%
Updated February 27 4:02 PM EST. Delayed by at least 15 minutes.

Hill-Rom Holdings Inc up (U.S.)$0.18

Hill-Rom Holdings Inc closed up Friday by (U.S.)$0.18 or 0.38% to (U.S.)$47.92. Over the last five days, shares have gained 0.25% and are currently 2.86% off of the 52-week high. Shares have outperformed the S&P 500 by 12.84% during the last year.

Key company metrics

  • Open(U.S.) $47.70
  • Previous close(U.S.) $47.74
  • High(U.S.) $48.23
  • Low(U.S.) $47.59
  • Bid / Ask-- / --
  • YTD % change+5.04%
  • Volume422,169
  • Average volume (10-day)280,352
  • Average volume (1-month)357,303
  • Average volume (3-month)389,486
  • 52-week range(U.S.) $35.45 to (U.S.) $49.33
  • Beta1.26
  • Trailing P/E47.02×
  • P/E 1 year forward19.29×
  • Forward PEG1.54×
  • Indicated annual dividend(U.S.) $0.61
  • Dividend yield1.27%
  • Trailing EPS(U.S.) $1.02
Updated February 27 4:02 PM EST. Delayed by at least 15 minutes.
S&P TSX0.04%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue465480398415
Total other revenue--------
Total revenue465480398415
Gross profit200213187203
Total cost of revenue265267211213
Total operating expense446444360388
Selling / general / administrative155152129130
Research & development22221816
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)45328
Other operating expenses, total--------
Operating income19353828
Interest income (expense), net non-operating-3-3-3-2
Gain (loss) on sale of assets--------
Other--------
Income before tax17343625
Income after tax122526-3
Income tax, total5101029
Net income122526-3
Total adjustments to net income--------
Net income before extra. items122526-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items122526-3
Inc. avail. to common incl. extra. items122526-3
Diluted net income122526-3
Dilution adjustment--------
Diluted weighted average shares58595857
Diluted EPS excluding extraordinary itemsvalue per share0.210.420.45-0.06
Dividends per sharevalue per share0.150.150.150.15
Diluted normalized EPSvalue per share-0.080.810.780.53